BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update
Go back to BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 3.20 +0.04 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.16 | 52 Week High | $1.63 | |||
| Open | $3.21 | 52 Week Low | $0.71 | |||
| Day High | $3.37 | P/E | N/A | |||
| Day Low | $3.17 | EPS | $0.00 | |||
| Volume | 9,069 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 3.20 +0.04 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.16 | 52 Week High | $1.63 | |||
| Open | $3.21 | 52 Week Low | $0.71 | |||
| Day High | $3.37 | P/E | N/A | |||
| Day Low | $3.17 | EPS | $0.00 | |||
| Volume | 9,069 | |||||

